Act Before 11:59pm: Last Day to SAVE 80% on Our Midcap Stocks Research
Here is the latest financial fact sheet of GENNEX LAB.. For more details, see the GENNEX LAB. quarterly results and GENNEX LAB. share price. For a sector overview, read our pharmaceuticals sector report.
1 Day | % | 2.2 |
No. of shares | m | 229.01 |
1 Week | % | 3.4 |
1 Month | % | 2.7 |
1 Year | % | 184.1 |
52 week H/L | Rs | 21.9/5.8 |
No. of Mths Year Ending |
12 Mar-19* |
12 Mar-20* |
12 Mar-21* |
12 Mar-22* |
12 Mar-23* |
5-Yr Chart Click to enlarge
|
---|
GENNEX LAB. EQUITY SHARE DATA | |||||||
---|---|---|---|---|---|---|---|
High | Rs | 6 | 4 | 6 | 13 | 9 | |
Low | Rs | 2 | 1 | 2 | 4 | 5 | |
Sales per share (Unadj.) | Rs | 4.1 | 4.1 | 4.4 | 4.5 | 3.4 | |
Earnings per share (Unadj.) | Rs | 0.2 | 0.1 | 0.3 | 0.3 | 0.3 | |
Diluted earnings per share | Rs | 0.1 | 0.1 | 0.2 | 0.2 | 0.2 | |
Cash flow per share (Unadj.) | Rs | 0.3 | 0.2 | 0.4 | 0.4 | 0.3 | |
Dividends per share (Unadj.) | Rs | 0 | 0 | 0 | 0 | 0 | |
Adj. dividends per share | Rs | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | |
Avg Dividend yield | % | 0 | 0 | 0 | 0 | 0 | |
Book value per share (Unadj.) | Rs | 2.7 | 2.8 | 3.1 | 3.5 | 4.5 | |
Adj. book value per share | Rs | 1.5 | 1.6 | 1.7 | 1.9 | 3.5 | |
Shares outstanding (eoy) | m | 126.50 | 126.50 | 126.50 | 126.50 | 176.64 | |
Price / Sales ratio | x | 1.0 | 0.7 | 0.9 | 1.9 | 2.1 | |
Avg P/E ratio | x | 22.6 | 19.5 | 12.3 | 27.0 | 25.0 | |
P/CF ratio (eoy) | x | 15.7 | 12.6 | 10.1 | 22.5 | 21.0 | |
Price / Book Value ratio | x | 1.5 | 1.0 | 1.3 | 2.4 | 1.5 | |
Dividend payout | % | 0 | 0 | 0 | 0 | 0 | |
Avg Mkt Cap | Rs m | 503 | 361 | 498 | 1,058 | 1,229 | |
Total wages/salary | Rs m | 61 | 68 | 72 | 70 | 79 |
GENNEX LAB. INCOME DATA | |||||||
---|---|---|---|---|---|---|---|
Net Sales | Rs m | 516 | 513 | 556 | 572 | 593 | |
Other income | Rs m | 8 | 10 | 5 | 14 | 40 | |
Total revenues | Rs m | 524 | 522 | 562 | 585 | 633 | |
Gross profit | Rs m | 40 | 34 | 62 | 54 | 47 | |
Depreciation | Rs m | 10 | 10 | 9 | 8 | 9 | |
Interest | Rs m | 8 | 8 | 7 | 9 | 14 | |
Profit before tax | Rs m | 30 | 25 | 51 | 51 | 64 | |
Minority Interest | Rs m | 0 | 0 | 0 | 0 | 0 | |
Prior Period Items | Rs m | 0 | 0 | 0 | 0 | 0 | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | 0 | 0 | 0 | |
Tax | Rs m | 8 | 7 | 10 | 12 | 15 | |
Profit after tax | Rs m | 22 | 19 | 40 | 39 | 49 | |
Gross profit margin | % | 7.8 | 6.5 | 11.1 | 9.4 | 7.9 | |
Effective tax rate | % | 26.6 | 27.2 | 20.2 | 23.0 | 22.8 | |
Net profit margin | % | 4.3 | 3.6 | 7.3 | 6.9 | 8.3 |
GENNEX LAB. BALANCE SHEET DATA | |||||||
---|---|---|---|---|---|---|---|
Current assets | Rs m | 290 | 350 | 364 | 472 | 487 | |
Current liabilities | Rs m | 173 | 209 | 190 | 242 | 295 | |
Net working cap to sales | % | 22.7 | 27.5 | 31.2 | 40.2 | 32.3 | |
Current ratio | x | 1.7 | 1.7 | 1.9 | 1.9 | 1.6 | |
Inventory Days | Days | 50 | 50 | 55 | 46 | 4 | |
Debtors Days | Days | 73,485,877 | 44,699,360 | 50,225,365 | 72,236,777 | 57,912,589 | |
Net fixed assets | Rs m | 227 | 220 | 225 | 208 | 835 | |
Share capital | Rs m | 127 | 127 | 127 | 127 | 180 | |
"Free" reserves | Rs m | 212 | 230 | 271 | 312 | 623 | |
Net worth | Rs m | 338 | 357 | 397 | 438 | 804 | |
Long term debt | Rs m | 0 | 0 | 0 | 0 | 163 | |
Total assets | Rs m | 517 | 569 | 589 | 680 | 1,322 | |
Interest coverage | x | 4.8 | 4.4 | 7.8 | 6.8 | 5.7 | |
Debt to equity ratio | x | 0 | 0 | 0 | 0 | 0.2 | |
Sales to assets ratio | x | 1.0 | 0.9 | 0.9 | 0.8 | 0.4 | |
Return on assets | % | 5.8 | 4.6 | 8.1 | 7.1 | 4.7 | |
Return on equity | % | 6.6 | 5.2 | 10.2 | 9.0 | 6.1 | |
Return on capital | % | 11.3 | 9.3 | 14.6 | 13.6 | 8.0 | |
Exports to sales | % | 45.5 | 42.9 | 41.2 | 56.2 | 42.1 | |
Imports to sales | % | 14.2 | 14.5 | 4.4 | 13.8 | 13.6 | |
Exports (fob) | Rs m | 235 | 220 | 229 | 321 | 250 | |
Imports (cif) | Rs m | 73 | 74 | 24 | 79 | 81 | |
Fx inflow | Rs m | 235 | 220 | 229 | 321 | 250 | |
Fx outflow | Rs m | 81 | 79 | 29 | 82 | 86 | |
Net fx | Rs m | 153 | 141 | 201 | 240 | 164 |
GENNEX LAB. CASH FLOW | |||||||
---|---|---|---|---|---|---|---|
From Operations | Rs m | 19 | -17 | -14 | 119 | 237 | |
From Investments | Rs m | -10 | -2 | -0 | -25 | -383 | |
From Financial Activity | Rs m | 12 | -3 | 16 | -18 | 210 | |
Net Cashflow | Rs m | 21 | -22 | 2 | 76 | 64 |
Share Holding
Shareholding as on Mar 2024
|
Company Information
|
CHM: Arihant Baid | COMP SEC: Dinesh Kumar Kejriwal | YEAR OF INC: 1990 | BSE CODE: 531739 | FV (Rs): 1 | DIV YIELD (%): - |
More Pharmaceuticals Company Fact Sheets: DIVIS LABORATORIES DR. REDDYS LAB SUN PHARMA ZYDUS LIFESCIENCES CIPLA
Compare GENNEX LAB. With: DIVIS LABORATORIES DR. REDDYS LAB SUN PHARMA ZYDUS LIFESCIENCES CIPLA
After opening the day on high, Indian share markets continued the momentum as the session progressed and ended the higher.